Han-xu Zeng

673 total citations
13 papers, 481 citations indexed

About

Han-xu Zeng is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Han-xu Zeng has authored 13 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Han-xu Zeng's work include Chronic Kidney Disease and Diabetes (4 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Han-xu Zeng is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Cancer-related molecular mechanisms research (3 papers) and Ferroptosis and cancer prognosis (3 papers). Han-xu Zeng collaborates with scholars based in China and Germany. Han-xu Zeng's co-authors include Ling Jiang, Yonggui Wu, Xue‐qi Liu, Yuebo Huang, Li Gao, Xiao‐Ming Meng, Xiangming Qi, Wei Zhu, Xian Wang and Jianan Wang and has published in prestigious journals such as PLoS ONE, Molecular Therapy and Autophagy.

In The Last Decade

Han-xu Zeng

13 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han-xu Zeng China	11	290	122	114	112	66	13	481
Rui Yan China	11	224 0.8×	104 0.9×	62 0.5×	46 0.4×	45 0.7×	36	446
Zhiyao Zhu China	11	432 1.5×	239 2.0×	198 1.7×	74 0.7×	39 0.6×	23	723
Dawei Zou China	10	404 1.4×	232 1.9×	206 1.8×	65 0.6×	34 0.5×	12	668
Xiaoxuan Bai China	9	259 0.9×	101 0.8×	33 0.3×	132 1.2×	91 1.4×	12	468
Xiuzhu Weng China	9	259 0.9×	101 0.8×	33 0.3×	132 1.2×	91 1.4×	13	468
Yunxia Du China	13	365 1.3×	57 0.5×	122 1.1×	66 0.6×	110 1.7×	30	601
Wangqiu Gong China	12	366 1.3×	197 1.6×	120 1.1×	34 0.3×	55 0.8×	15	607
Fuzhe Ma China	13	212 0.7×	110 0.9×	96 0.8×	26 0.2×	42 0.6×	25	426
Lingfeng Zeng China	10	211 0.7×	66 0.5×	149 1.3×	37 0.3×	28 0.4×	23	450
Xing Mao China	11	171 0.6×	51 0.4×	159 1.4×	43 0.4×	49 0.7×	18	446

Countries citing papers authored by Han-xu Zeng

Since Specialization

Citations

This map shows the geographic impact of Han-xu Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-xu Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-xu Zeng more than expected).

Fields of papers citing papers by Han-xu Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han-xu Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-xu Zeng. The network helps show where Han-xu Zeng may publish in the future.

Co-authorship network of co-authors of Han-xu Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Han-xu Zeng. A scholar is included among the top collaborators of Han-xu Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han-xu Zeng. Han-xu Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Liu, Xueqi, Mengya Zhang, Lang Zhou, et al.. (2023). Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-mediated ferroptosis. International Immunopharmacology. 116. 109754–109754. 32 indexed citations

Liu, Xueqi, Ling Jiang, Han-xu Zeng, et al.. (2023). Circ-0000953 deficiency exacerbates podocyte injury and autophagy disorder by targeting Mir665-3p-Atg4b in diabetic nephropathy. Autophagy. 20(5). 1072–1097. 30 indexed citations

Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations

Huang, Yuebo, Ling Jiang, Xue‐qi Liu, et al.. (2022). Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis‐Mediated Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4776243–4776243. 51 indexed citations

Wang, Xian, Ling Jiang, Xue‐qi Liu, et al.. (2022). Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Phytomedicine. 106. 154400–154400. 46 indexed citations

Wang, Xian, et al.. (2022). Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1945–1959. 9 indexed citations

Li, Dashan, Yuanyuan Li, Han-xu Zeng, & Yonggui Wu. (2022). Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis. PLoS ONE. 17(3). e0265584–e0265584. 2 indexed citations

Wang, Xian, Xue‐qi Liu, Ling Jiang, et al.. (2022). Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease. Frontiers in Pharmacology. 13. 966645–966645. 20 indexed citations

Liu, Xue‐qi, Mingming Liu, Ling Jiang, et al.. (2022). A novel small molecule Hsp90 inhibitor, C-316-1, attenuates acute kidney injury by suppressing RIPK1-mediated inflammation and necroptosis. International Immunopharmacology. 108. 108849–108849. 22 indexed citations

10.

Wang, Xian, Ling Jiang, Xue‐Qi Liu, et al.. (2022). Identification of Genes Reveals the Mechanism of Cell Ferroptosis in Diabetic Nephropathy. Frontiers in Physiology. 13. 890566–890566. 16 indexed citations

11.

Li, Yuanyuan, Han-xu Zeng, Xue‐qi Liu, et al.. (2021). Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis. International Immunopharmacology. 101(Pt B). 108236–108236. 44 indexed citations

12.

Zeng, Han-xu, Xiangming Qi, Xingxin Xu, & Yonggui Wu. (2020). TAB1 regulates glycolysis and activation of macrophages in diabetic nephropathy. Inflammation Research. 69(12). 1215–1234. 33 indexed citations

13.

Liu, Xue‐qi, Ling Jiang, Lei Lei, et al.. (2020). Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis. Clinical Science. 134(23). 3175–3193. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact